tallimustine has been researched along with Benign Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalli, F; de Jong, J; Hofmann, C; Lassus, M; Marrari, P; Pagani, O; Sessa, C; Strolin Benedetti, M; Zurlo, MG | 1 |
| Citti, L; D'Incalci, M; Damia, G; Imperatori, L; Mariani, L | 1 |
| DeMaria, D; Mooneyham, T; O'Dwyer, P; Patricia, E; Poggesi, I; Reilly, D; Rocchetti, M; Vitek, LV; Von Hoff, DD; Weiss, GR; Whaley, F | 1 |
| Broggini, M; Cirò, M; Cozzi, P; D'Incalci, M; Gallinari, F; Geroni, C; Marchini, S | 1 |
2 trial(s) available for tallimustine and Benign Neoplasms
| Article | Year |
|---|---|
Phase I study of the novel distamycin derivative tallimustine (FCE 24517).
Topics: Adult; Aged; Antineoplastic Agents; Distamycins; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Nitrogen Mustard Compounds; Remission Induction | 1994 |
A phase I and pharmacokinetic study of tallimustine [PNU 152241 (FCE 24517)] in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Agents; Distamycins; Female; Humans; Male; Middle Aged; Neoplasms; Nitrogen Mustard Compounds | 1998 |
2 other study(ies) available for tallimustine and Benign Neoplasms
| Article | Year |
|---|---|
3-methyladenine-DNA-glycosylase and O6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines.
Topics: Alkylating Agents; Antineoplastic Agents, Alkylating; Carcinogens; Cell Division; Cisplatin; Distamycins; DNA Glycosylases; Humans; Melphalan; Methylnitronitrosoguanidine; Methyltransferases; N-Glycosyl Hydrolases; Neoplasms; Nitrogen Mustard Compounds; O(6)-Methylguanine-DNA Methyltransferase; RNA, Messenger; Sensitivity and Specificity; Sulfuric Acid Esters; Tumor Cells, Cultured | 1996 |
Alpha-bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity.
Topics: Animals; bcl-2-Associated X Protein; Blotting, Western; CDC2-CDC28 Kinases; Cell Cycle; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Distamycins; DNA; DNA Footprinting; Drug Screening Assays, Antitumor; Humans; Mice; Neoplasms; Nitrogen Mustard Compounds; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |